{
  "created_at": "Mon Jun 07 20:33:38 +0000 2021",
  "id_str": "1401922146327306243",
  "full_text": "Breaking News: The F.D.A. approved a medication for Alzheimer’s, the first in nearly two decades, despite a fierce debate among experts over whether it works. https://t.co/ypDII3KNSb",
  "display_text_range": [
    0,
    182
  ],
  "entities": {
    "hashtags": [],
    "symbols": [],
    "user_mentions": [],
    "urls": [
      {
        "url": "https://t.co/ypDII3KNSb",
        "expanded_url": "https://nyti.ms/3psdea2",
        "display_url": "nyti.ms/3psdea2",
        "indices": [
          159,
          182
        ]
      }
    ]
  },
  "user": {
    "name": "The New York Times",
    "screen_name": "nytimes",
    "profile_image_url_https": "https://pbs.twimg.com/profile_images/1098244578472280064/gjkVMelR_normal.png"
  },
  "retweet_count": 238,
  "favorite_count": 611,
  "possibly_sensitive": false,
  "original_created_at": "Mon Jun 07 15:21:00 +0000 2021",
  "localize": [
    {
      "locale": "ja",
      "full_text": "速報です。F.D.A.は、アルツハイマー病の治療薬を約20年ぶりに承認しました。専門家の間では、効果があるかどうかについて激しい議論がありましたが、https://t.co/ypDII3KNSb。"
    },
    {
      "locale": "zh",
      "full_text": "突发新闻。尽管专家们对阿尔茨海默氏症是否有效存在着激烈的争论，但联邦药品管理局批准了一种治疗阿尔茨海默氏症的药物，这是近二十年来的第一次。https://t.co/ypDII3KNSb。"
    },
    {
      "locale": "zh-Hant",
      "full_text": "突發新聞。儘管專家們對阿爾茨海默氏症是否有效存在着激烈的爭論，但聯邦藥品管理局批准了一種治療阿爾茨海默氏症的藥物，這是近二十年來的第一次。https://t.co/ypDII3KNSb。"
    }
  ]
}